Also trades as: DXRX.L (LSE) · $vol 1M
DIUXF OTC
Diaceutics PLC
1W: +15.5%
1M: +15.5%
3M: +15.5%
YTD: +68.6%
1Y: +68.6%
3Y: +68.6%
5Y: +53.0%
$2.31
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$651K
-50.3% ▼
Capital Expenditures
$5M
+4.6% ▲
5Y CAGR: +9.6%
Free Cash Flow
-$4M
-12.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$4M
-23.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $263K | $561K | $724K | -$2M | -$2M |
| Depreciation & Amort. | $809K | $2M | $3M | $5M | $5M |
| Stock-Based Comp. | $290K | $373K | $536K | $445K | $1M |
| Change in Working Capital | $486K | -$2M | -$328K | -$2M | -$1M |
| Other Non-Cash Items | -$173K | $5M | $8M | -$621K | -$2M |
| Operating Cash Flow | $253K | $570K | $5M | $1M | $651K |
| — Investing Activities — | |||||
| Capital Expenditures | -$6M | -$6M | -$5M | -$125K | -$100K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$6M | -$5M | -$5M | -$4M | -$4M |
| Investing Cash Flow | -$6M | -$6M | -$5M | -$4M | -$4M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$56K | $0 | $0 | -$199K |
| Stock Repurchased | $0 | -$165K | -$98K | -$49K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$49K | -$163K | -$190K | -$1K |
| Financing Cash Flow | $20M | -$270K | -$132K | -$239K | -$64K |
| Net Change in Cash | $14M | -$6M | $166K | -$3M | -$4M |
| Cash End of Period | $25M | $20M | $20M | $17M | $13M |
| Free Cash Flow | -$6M | -$5M | $278K | -$4M | -$4M |